inVentiv buys Kazaam to boost digital commercial services
inVentiv Health will expand its digital and social media commercial services following the takeover of Kazaam Interactive.
Archives for June 6, 2012
EMA adopts plan for handling GMP info from third-parties
The EMA has adopted a policy for handling GMP non-compliance information from other regulators or international organisations.
Covance site closure prompts sales push at Charles River
Charles River Laboratories is “aggressively” pursuing biopharma firms hit by the closure of Covance’s Arizona toxicology facility.
Round up of drug delivery news
in-PharmaTechnologist.com presents a roundup of drug delivery news, including a FDA set back at Amylin and expansion at Particle Sciences.
UPDATE
Pricing schemes stunts UK pharma manufacturing market's growth: report
The UK pharma manufacturing market is predicted to see a modest 2.7 per cent growth over the next five years largely due to pricing schemes set by the Government, according to a new report.
Indena on the environmental standard trail
Milan head-quartered plant extract specialist, Indena, has been granted the ISO14001 certification for its Tours production site in France, marking the second for its five production sites.
FDA warns 8 manufacturers for failing to register plants
The US FDA has sent warning letters to eight biopharma companies for failing to register production facilities.
Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles
Negotiating funding for drugs with local health authorities prior to commercialisation is the key to success for biopharmas working in the changing European market, says Quintiles.